Modeling the Relationship Between Diastolic Phenotype and Outcomes in Pediatric Hypertrophic Cardiomyopathy

Minh B Nguyen1, Maelys Venet2, Chun-Po Steve Fan3

  • 1Department of Pediatric Cardiology, Baylor College of Medicine, Houston, Texas; Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Insights

Diastolic dysfunction in pediatric hypertrophic cardiomyopathy (HCM) is linked to adverse events. Left atrial size, adjusted for body surface area, independently predicts adverse outcomes in these children.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Imaging
  • Genetic Cardiology

Background:

  • Pediatric hypertrophic cardiomyopathy (HCM) carries a risk of adverse events.
  • The role of diastolic dysfunction in pediatric HCM outcomes is not well understood.
  • This study investigates the association between diastolic phenotype and adverse events in pediatric HCM.

Purpose of the Study:

  • To explore the association between diastolic dysfunction and major adverse cardiac events (MACE) in pediatric patients with HCM.
  • To identify key echocardiographic parameters predictive of MACE in this population.
  • To understand the contribution of diastolic function to adverse outcomes in pediatric HCM.

Main Methods:

  • Principal component analysis of echocardiographic diastolic function parameters in pediatric HCM patients.
  • Regression analysis of principal components against freedom from MACE.
  • MACE included ICD insertion, myectomy, aborted SCD, transplantation, mechanical support, or death.

Main Results:

  • Left atrial size parameters, adjusted for body surface area, were independently associated with MACE (HR, 0.69; 95% CI, 0.5-0.94).
  • Left ventricular filling pressure variables showed an association with MACE, but this was not significant after adjusting for left ventricular thickness and genetic variation.
  • The final covariate-adjusted model demonstrated strong predictive performance for MACE (concordance index, 0.82).

Conclusions:

  • Diastolic dysfunction parameters, left ventricular hypertrophy severity, and genetic variation are associated with MACE in pediatric HCM.
  • Left atrial size adjusted for body surface area is an independent predictor of adverse events.
  • Further research on size-adjusted diastolic function parameters may improve adverse event prediction in pediatric HCM.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...